Eisai Co., Ltd. (4523.T)
JPY 4271.0
(2.89%)
JPY 4271.0
(2.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 586.41 Billion JPY | -0.49% |
| 2022 | 566.56 Billion JPY | -2.55% |
| 2021 | 581.39 Billion JPY | 19.97% |
| 2020 | 484.63 Billion JPY | -6.79% |
| 2019 | 519.92 Billion JPY | 13.44% |
| 2018 | 458.34 Billion JPY | 14.93% |
| 2017 | 398.8 Billion JPY | 16.2% |
| 2016 | 343.19 Billion JPY | -2.91% |
| 2015 | 353.46 Billion JPY | -0.4% |
| 2014 | 354.87 Billion JPY | -13.91% |
| 2013 | 412.19 Billion JPY | 3.16% |
| 2012 | 399.56 Billion JPY | -15.81% |
| 2011 | 474.57 Billion JPY | -21.06% |
| 2010 | 601.14 Billion JPY | -6.42% |
| 2009 | 642.41 Billion JPY | 2.08% |
| 2008 | 629.29 Billion JPY | 2.24% |
| 2007 | 615.48 Billion JPY | 8.97% |
| 2006 | 564.8 Billion JPY | 13.7% |
| 2005 | 496.74 Billion JPY | 14.32% |
| 2004 | 434.52 Billion JPY | 7.84% |
| 2003 | 402.94 Billion JPY | 10.66% |
| 2002 | 364.14 Billion JPY | 10.29% |
| 2001 | 330.18 Billion JPY | 25.49% |
| 2000 | 263.11 Billion JPY | 24.82% |
| 1999 | 210.78 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 149.27 Billion JPY | -3.31% |
| 2023 Q2 | 140.19 Billion JPY | -8.38% |
| 2023 FY | 563.77 Billion JPY | -0.49% |
| 2023 Q4 | 154.39 Billion JPY | 11.21% |
| 2023 Q3 | 138.82 Billion JPY | -0.98% |
| 2023 Q1 | 153.01 Billion JPY | -4.15% |
| 2022 FY | 566.56 Billion JPY | -2.55% |
| 2022 Q2 | 129.23 Billion JPY | -5.57% |
| 2022 Q3 | 140.83 Billion JPY | 8.98% |
| 2022 Q4 | 159.64 Billion JPY | 13.35% |
| 2022 Q1 | 136.85 Billion JPY | -2.36% |
| 2021 FY | 581.39 Billion JPY | 19.97% |
| 2021 Q2 | 122.83 Billion JPY | -23.06% |
| 2021 Q1 | 159.64 Billion JPY | 49.96% |
| 2021 Q3 | 158.75 Billion JPY | 29.24% |
| 2021 Q4 | 140.16 Billion JPY | -11.71% |
| 2020 Q1 | 127.3 Billion JPY | -20.95% |
| 2020 FY | 484.63 Billion JPY | -6.79% |
| 2020 Q2 | 110.03 Billion JPY | -13.57% |
| 2020 Q4 | 106.46 Billion JPY | -24.41% |
| 2020 Q3 | 140.83 Billion JPY | 28.0% |
| 2019 Q3 | 142.8 Billion JPY | 36.04% |
| 2019 FY | 519.92 Billion JPY | 13.44% |
| 2019 Q1 | 111.11 Billion JPY | -16.35% |
| 2019 Q4 | 161.04 Billion JPY | 12.78% |
| 2019 Q2 | 104.97 Billion JPY | -5.53% |
| 2018 Q4 | 132.82 Billion JPY | 23.65% |
| 2018 Q2 | 112.84 Billion JPY | 7.21% |
| 2018 Q1 | 105.25 Billion JPY | -8.51% |
| 2018 Q3 | 107.41 Billion JPY | -4.81% |
| 2018 FY | 458.34 Billion JPY | 14.93% |
| 2017 FY | 398.8 Billion JPY | 16.2% |
| 2017 Q3 | 100.82 Billion JPY | 11.46% |
| 2017 Q2 | 90.46 Billion JPY | -2.16% |
| 2017 Q1 | 92.45 Billion JPY | 12.98% |
| 2017 Q4 | 115.05 Billion JPY | 14.11% |
| 2016 Q2 | 84.59 Billion JPY | -2.89% |
| 2016 FY | 343.19 Billion JPY | -2.91% |
| 2016 Q3 | 89.65 Billion JPY | 5.98% |
| 2016 Q1 | 87.11 Billion JPY | 14.17% |
| 2016 Q4 | 81.83 Billion JPY | -8.72% |
| 2015 Q1 | 89.84 Billion JPY | 0.4% |
| 2015 Q2 | 86.17 Billion JPY | -4.08% |
| 2015 Q4 | 76.29 Billion JPY | -24.57% |
| 2015 Q3 | 101.15 Billion JPY | 17.38% |
| 2015 FY | 353.46 Billion JPY | -0.4% |
| 2014 Q1 | 84.69 Billion JPY | -19.88% |
| 2014 Q4 | 89.47 Billion JPY | -0.74% |
| 2014 Q2 | 90.54 Billion JPY | 6.91% |
| 2014 Q3 | 90.14 Billion JPY | -0.44% |
| 2014 FY | 354.87 Billion JPY | -13.91% |
| 2013 Q2 | 104.53 Billion JPY | -3.17% |
| 2013 FY | 412.19 Billion JPY | 3.16% |
| 2013 Q4 | 105.71 Billion JPY | 22.2% |
| 2013 Q3 | 86.51 Billion JPY | -17.24% |
| 2013 Q1 | 107.96 Billion JPY | 12.28% |
| 2012 Q3 | 99.91 Billion JPY | 0.14% |
| 2012 Q4 | 96.15 Billion JPY | -3.77% |
| 2012 Q1 | 103.72 Billion JPY | 4.68% |
| 2012 FY | 399.56 Billion JPY | -15.81% |
| 2012 Q2 | 99.77 Billion JPY | -3.81% |
| 2011 Q4 | 99.08 Billion JPY | -23.86% |
| 2011 Q2 | 121.05 Billion JPY | -2.6% |
| 2011 FY | 474.57 Billion JPY | -21.06% |
| 2011 Q1 | 124.29 Billion JPY | 8.45% |
| 2011 Q3 | 130.13 Billion JPY | 7.5% |
| 2010 Q1 | 160.92 Billion JPY | 0.91% |
| 2010 Q4 | 114.6 Billion JPY | -27.63% |
| 2010 FY | 601.14 Billion JPY | -6.42% |
| 2010 Q3 | 158.37 Billion JPY | -5.31% |
| 2010 Q2 | 167.24 Billion JPY | 3.93% |
| 2009 Q3 | 166.87 Billion JPY | 4.47% |
| 2009 Q4 | 159.46 Billion JPY | -4.44% |
| 2009 FY | 642.41 Billion JPY | 2.08% |
| 2009 Q1 | 156.33 Billion JPY | 4.6% |
| 2009 Q2 | 159.73 Billion JPY | 2.18% |
| 2008 Q3 | 160.23 Billion JPY | -1.78% |
| 2008 FY | 629.29 Billion JPY | 2.24% |
| 2008 Q1 | 156.46 Billion JPY | 0.0% |
| 2008 Q2 | 163.14 Billion JPY | 4.26% |
| 2008 Q4 | 149.45 Billion JPY | -6.73% |
| 2007 FY | 615.48 Billion JPY | 8.97% |
| 2006 FY | 564.8 Billion JPY | 13.7% |
| 2005 FY | 496.74 Billion JPY | 14.32% |
| 2004 FY | 434.52 Billion JPY | 7.84% |
| 2003 FY | 402.94 Billion JPY | 10.66% |
| 2002 FY | 364.14 Billion JPY | 10.29% |
| 2001 FY | 330.18 Billion JPY | 25.49% |
| 2000 FY | 263.11 Billion JPY | 24.82% |
| 1999 FY | 210.78 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -1102.859% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 73.161% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | -211.956% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | -58.884% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -16461.513% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | -504.449% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -1434.242% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -9676.892% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -642.574% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -1026.211% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -4238.374% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -7478.418% |
| Tsumura & Co. | 68.81 Billion JPY | -752.141% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -1470.44% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -2265.352% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | -620.566% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -3450.82% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -1068.598% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -1040.891% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -54248.285% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -5860.138% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -13194.404% |
| MedRx Co., Ltd | 26 Million JPY | -2255353.846% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -7206.737% |
| Solasia Pharma K.K. | 337 Million JPY | -173911.276% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 80221440.629% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -1812.337% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -979.582% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -1553572.107% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | -419.023% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -8732.126% |